✦ LIBER ✦

P4-353 Targeting megalin as a possible therapeutic alternative in Alzheimer's disease

✍ Scribed by Carro, Eva

Book ID: 123108875
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 158 KB
Volume: 25
Category: Article
ISSN: 0197-4580
DOI: 10.1016/S0197-4580(04)81911-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hypometabolism as a therapeutic target i

Hypometabolism as a therapeutic target in Alzheimer's disease

✍ Lauren C Costantini; Linda J Barr; Janet L Vogel; Samuel T Henderson 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 331 KB

Hypometabolism as a therapeutic target i

Hypometabolism as a therapeutic target in Alzheimer's disease

✍ Lauren C Costantini; Linda J Barr; Janet L Vogel; Samuel T Henderson 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 331 KB

The pathology of Alzheimer's disease (AD) is characterized by cerebral atrophy in frontal, temporal, and parietal regions, with senile plaques, dystrophic neurites, and neurofibrillar tangles within defined areas of the brain. Another characteristic of AD is regional hypometabolism in the brain. Thi

P4-169: Mitochondrially targeted antioxi

P4-169: Mitochondrially targeted antioxidant therapeutics in Alzheimer's disease

✍ Reddy, P. Hemachandra; Manczak, Maria; Zhao, Wei 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

NADPH oxidase as a therapeutic target in

NADPH oxidase as a therapeutic target in Alzheimer's disease

✍ Michelle L Block 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 480 KB

Cellular Prion Protein as a Therapeutic

Cellular Prion Protein as a Therapeutic Target in Alzheimer's Disease

✍ Laurén, Juha 📂 Article 📅 2013 🏛 IOS Press 🌐 English ⚖ 572 KB

P4-303: Sorafenib as a therapeutic agent

P4-303: Sorafenib as a therapeutic agent against Alzheimer's disease

✍ Moran, Valentina Echeverria; Gamble-George, Joyonna; Burgess, Sarah; Dickson, Al 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB